These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 16697585)

  • 1. [Immunization in France: high quality regulation].
    Fuchs F
    Arch Pediatr; 2006 Jun; 13(6):648-50. PubMed ID: 16697585
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunization: adverse event reporting system].
    Weil-Olivier C; Jacquet A
    Arch Pediatr; 2006 Jun; 13(6):646-8. PubMed ID: 16697590
    [No Abstract]   [Full Text] [Related]  

  • 3. Risk management ... National Childhood Vaccine Injury Act of 1986.
    Toreki W
    Trends Health Care Law Ethics; 1992; 7(2):41-4. PubMed ID: 1576475
    [No Abstract]   [Full Text] [Related]  

  • 4. [Vaccines' adverse events: questions and answers brought by InfoVac].
    Cohen R; Siegrist CA
    Arch Pediatr; 2006 Jun; 13(6):650-2. PubMed ID: 16690277
    [No Abstract]   [Full Text] [Related]  

  • 5. Standards for child and adolescent immunization practices. National Vaccine Advisory Committee.
    National Vaccine Advisory Committee
    Pediatrics; 2003 Oct; 112(4):958-63. PubMed ID: 14523192
    [No Abstract]   [Full Text] [Related]  

  • 6. The development of standardized case definitions and guidelines for adverse events following immunization.
    Kohl KS; Gidudu J; Bonhoeffer J; Braun MM; Buettcher M; Chen RT; Drammeh B; Duclos P; Heijbel H; Heininger U; Hummelman E; Jefferson T; Keller-Stanislawski B; Loupi E; Marcy SM
    Vaccine; 2007 Aug; 25(31):5671-4. PubMed ID: 17400339
    [No Abstract]   [Full Text] [Related]  

  • 7. [Safe drugs for children].
    Krankenpfl J; 2004; 42(7-10):230. PubMed ID: 15675392
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of the pharmaceutical industry in disseminating pharmacovigilance practice in developing countries.
    Shani S; Yahalom Z
    Food Drug Law J; 2008; 63(3):701-11. PubMed ID: 19031669
    [No Abstract]   [Full Text] [Related]  

  • 9. [Network for investigation of medicinal products in children].
    Kassaï B; Treluyer JM; Jacqz-Aigrain E; Pons G
    Arch Pediatr; 2006 Jun; 13(6):631-4. PubMed ID: 16697606
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of editorial peer review in the evaluation of vaccine safety.
    Jefferson T
    Vaccine; 2004 May; 22(15-16):2073-5. PubMed ID: 15121326
    [No Abstract]   [Full Text] [Related]  

  • 11. [European drug agency and drug management].
    Barfuss W
    Leber Magen Darm; 1996 Jul; 26(4):191-2. PubMed ID: 8965600
    [No Abstract]   [Full Text] [Related]  

  • 12. [Drug indications and the physician's treatment choice].
    Deutsch E
    Internist (Berl); 1995 Aug; 36(8):837-9. PubMed ID: 7558704
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effective and safe drugs. A constant challenge].
    Scheler F
    Internist (Berl); 1995 May; 36(5):511-5. PubMed ID: 7601624
    [No Abstract]   [Full Text] [Related]  

  • 14. Simultaneous vaccination of Chinese applicants for a United States immigrant visa.
    Hua L; Hongtao H; Shunqin W; Jinping G; Jiandong C; Zhaoliang L; Xinwen F
    Travel Med Infect Dis; 2008 May; 6(3):130-6. PubMed ID: 18486068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse events temporally associated with vaccines--1992 report.
    Bentsi-Enchill A; Hardy M; Koch J; Duclos P
    Can Commun Dis Rep; 1995 Jul; 21(13):117-28. PubMed ID: 7663460
    [No Abstract]   [Full Text] [Related]  

  • 16. [Modification of the prescribing practice of the physician by drug approval decisions of federal agencies].
    Wartensleben H
    Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):604-6. PubMed ID: 9527450
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hospital network in pediatric oncology].
    Doz F
    Arch Pediatr; 2006 Jun; 13(6):635-7. PubMed ID: 16697587
    [No Abstract]   [Full Text] [Related]  

  • 18. No blame--no gain.
    Templeman-Kluit A
    CMAJ; 2008 Jan; 178(2):140-1. PubMed ID: 18195280
    [No Abstract]   [Full Text] [Related]  

  • 19. An innovative advance to increase the use of the vaccine information statement.
    Edlich RF; Olson DM; Olson BM; Greene JA; Gubler KD; Winters KL; Poe MJ; Britt LD; Long WB
    J Emerg Med; 2007 Jul; 33(1):81-9. PubMed ID: 17630084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse events temporally associated with immunizing agents--1989 report.
    Duclos P; Koch J; Hardy M; Carter A; McCarthy R
    Can Dis Wkly Rep; 1991 Jul; 17(29):147-51, 155-7. PubMed ID: 1913934
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.